Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.

Heinbockel L, Sánchez-Gómez S, Martinez de Tejada G, Dömming S, Brandenburg J, Kaconis Y, Hornef M, Dupont A, Marwitz S, Goldmann T, Ernst M, Gutsmann T, Schürholz T, Brandenburg K.

Antimicrob Agents Chemother. 2013 Mar;57(3):1480-7. doi: 10.1128/AAC.02066-12. Epub 2013 Jan 14.

PMID:
23318793
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.

Giacometti A, Cirioni O, Ghiselli R, Dell'Acqua G, Orlando F, D'Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G.

Peptides. 2005 Feb;26(2):169-75.

PMID:
15629527
[PubMed - indexed for MEDLINE]
3.

Endotoxin-neutralizing activity of hen egg phosvitin.

Ma J, Wang H, Wang Y, Zhang S.

Mol Immunol. 2013 Apr;53(4):355-62. doi: 10.1016/j.molimm.2012.09.006. Epub 2012 Oct 16.

PMID:
23079731
[PubMed - indexed for MEDLINE]
4.

RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.

Ghiselli R, Giacometti A, Cirioni O, Dell'Acqua G, Bergnach C, Orlando F, Mocchegiani F, Silvestri C, Skerlavaj B, Licci A, Balaban N, Zanetti M, Scalise G, Saba V.

Shock. 2006 Sep;26(3):296-301.

PMID:
16912656
[PubMed - indexed for MEDLINE]
5.

Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.

Ahn JY, Song JY, Yun YS, Jeong G, Choi IS.

FEMS Immunol Med Microbiol. 2006 Mar;46(2):187-97.

PMID:
16487300
[PubMed - indexed for MEDLINE]
6.

Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence.

Wyatt MA, Wang W, Roux CM, Beasley FC, Heinrichs DE, Dunman PM, Magarvey NA.

Science. 2010 Jul 16;329(5989):294-6. doi: 10.1126/science.1188888. Epub 2010 Jun 3. Erratum in: Science. 2011 Sep 9;333(6048):1381.

PMID:
20522739
[PubMed - indexed for MEDLINE]
Free Article
7.

Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.

Richter SG, Elli D, Kim HK, Hendrickx AP, Sorg JA, Schneewind O, Missiakas D.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3531-6. doi: 10.1073/pnas.1217337110. Epub 2013 Feb 11.

PMID:
23401520
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.

Alp E, Gozukucuk S, Canoz O, Kirmaci B, Doganay M.

BMC Infect Dis. 2004 Oct 18;4:43.

PMID:
15491501
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.

Ebert T, Smith S, Pancari G, Clark D, Hampton R, Secore S, Towne V, Fan H, Wang XM, Wu X, Ernst R, Harvey BR, Finnefrock AC, Wang F, Tan C, Durr E, Cope L, Anderson A, An Z, McNeely T.

Hum Antibodies. 2010;19(4):113-28. doi: 10.3233/HAB-2010-0235.

PMID:
21178283
[PubMed - indexed for MEDLINE]
10.

Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.

Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, Hufnagle WO, Folger KR, Bayer AS, Stover CK.

Mol Microbiol. 1998 Oct;30(2):393-404.

PMID:
9791183
[PubMed - indexed for MEDLINE]
11.

Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.

Yoshizawa S, Tateda K, Saga T, Ishii Y, Yamaguchi K.

Antimicrob Agents Chemother. 2012 Apr;56(4):1744-8. doi: 10.1128/AAC.05430-11. Epub 2012 Jan 30.

PMID:
22290944
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Activity of beta-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus.

Ling JM, Lam AW, Cheng AF, French GL.

J Antimicrob Chemother. 1993 Dec;32(6):919-20. No abstract available.

PMID:
8144442
[PubMed - indexed for MEDLINE]
13.

A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.

Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.

Int Immunopharmacol. 2004 Apr;4(4):527-37.

PMID:
15099530
[PubMed - indexed for MEDLINE]
14.

Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.

Hirata M, Shimomura Y, Yoshida M, Wright SC, Larrick JW.

Prog Clin Biol Res. 1994;388:147-59.

PMID:
7831355
[PubMed - indexed for MEDLINE]
15.

In vivo experimental model for the study of the influence of subinhibitory concentrations of phenyllactic acid on Staphylococcus aureus pathogenicity.

Chifiriuc MC, Bleotu C, Ditu LM, Smarandache D, Săsărman E, Banu O, Drăcea O, Larion C, Veronica L.

Roum Arch Microbiol Immunol. 2009 Jan-Mar;68(1):34-7.

PMID:
19507625
[PubMed - indexed for MEDLINE]
16.

Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.

Kaplan N, Albert M, Awrey D, Bardouniotis E, Berman J, Clarke T, Dorsey M, Hafkin B, Ramnauth J, Romanov V, Schmid MB, Thalakada R, Yethon J, Pauls HW.

Antimicrob Agents Chemother. 2012 Nov;56(11):5865-74. doi: 10.1128/AAC.01411-12. Epub 2012 Sep 4.

PMID:
22948878
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.

Cirioni O, Ghiselli R, Orlando F, Silvestri C, De Luca S, Salzano AM, Mocchegiani F, Saba V, Scalise G, Scaloni A, Giacometti A.

Crit Care Med. 2008 Sep;36(9):2629-33. doi: 10.1097/CCM.0b013e318184430d.

PMID:
18679116
[PubMed - indexed for MEDLINE]
18.

Targeting MgrA-mediated virulence regulation in Staphylococcus aureus.

Sun F, Zhou L, Zhao BC, Deng X, Cho H, Yi C, Jian X, Song CX, Luan CH, Bae T, Li Z, He C.

Chem Biol. 2011 Aug 26;18(8):1032-41. doi: 10.1016/j.chembiol.2011.05.014.

PMID:
21867918
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Future strategies for treating Staphylococcus aureus bloodstream infections.

Naber CK.

Clin Microbiol Infect. 2008 Mar;14 Suppl 2:26-34. doi: 10.1111/j.1469-0691.2008.01924.x. Review.

PMID:
18226087
[PubMed - indexed for MEDLINE]
20.

Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.

Pan CY, Chao TT, Chen JC, Chen JY, Liu WC, Lin CH, Kuo CM.

Int Immunopharmacol. 2007 May;7(5):687-700. Epub 2007 Feb 7.

PMID:
17386416
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk